Abstract Background: Cannabinoids are studied as anticancer agents, but their effects vary across tumors, compounds, and experimental settings, underscoring the…
Abstract Introduction and Aim: Assessment of antitumor activity in preclinical models remains challenging when relying solely on conventional size-based imaging,…
Abstract Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and frequently co-occurs with chronic pain.…
Abstract Aging is characterized in part by chronic, low-grade inflammation, a major driver of cognitive decline, metabolic imbalance and organ…
Abstract Introduction: Cannabinoids hold promise in oncology for symptom relief and antitumor effects, though concerns about safety and efficacy persist.…
Abstract Background: Aging is a multifaceted process marked by the progressive accumulation of cellular damage in various tissues, resulting in…
Abstract Purpose of the Review: As cancer survival rates are increasing, alternative treatments to improve quality of life, such as…
Abstract The increasing prevalence of dementia within an ageing global population, combined with prolonged life expectancy, accentuates Alzheimer’s disease (AD)…
Abstract Chemotherapy-induced neuropathic pain (CINP), a condition with unmet treatment needs, affects over half of cancer patients treated with chemotherapeutics.…
Abstract Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a shared burden for 68.1% of oncological patients undergoing chemotherapy with Paclitaxel (PTX).…